Appearances:

﻿

Phar-East Day 1 @ 09:40

Pharma Trends: Women health as the next focus

By 2023, it is estimated that the women’s health market will be worth $37.4 billion. But despite this impressive growth, across the world there are still significant unmet needs in the space. In this panel discussion, we will explore the significant opportunities in the women’s health market, from drug discovery and development to effective clinical trials and ensuring access to treatment, including both strategy development and technology advances.

Rhenu Bhuller / Pharma Trends: Women health as the next focus

Rhenu Bhuller, Partner,Frost & Sullivan

With more than 20 years of experience in life sciences, medical technology and business evaluations, Rhenu works with Frost & Sullivan’s Transformational Health analysts in tracking key issues globally related to healthcare access, digital transformation, as well as how market trends and...